<DOC>
	<DOCNO>NCT00418951</DOCNO>
	<brief_summary>The goal clinical research study compare effectiveness liposomal amphotericin B give three time per week , versus liposomal amphotericin B give per week , versus oral voriconazole prevention fungal infection patient acute myeloid leukemia ( AML ) myelodysplastic syndrome MDS receive chemotherapy . The safety treatment also study compare .</brief_summary>
	<brief_title>Liposomal Amphotericin B ( Ambisome ) Versus Oral Voriconazole Prevention Invasive Fungal Infections</brief_title>
	<detailed_description>Ambisome voriconazole drug use fight fungal infection , typically occur chemotherapy result lower immune system function . Ambisome work bind sterol component fungal cell membrane . This cause `` hole '' appear membrane , lead death fungal cell . Voriconazole inhibit essential step biosynthesis important component fungal cell wall ( ergosterol ) . This cause impairment fungal cell wall . Before start treatment study , `` screening test . '' These test help doctor decide eligible take part study . You ask question medical history . You complete physical exam chest x-ray . You compute tomography ( CT ) scan chest . You also 1 teaspoon blood drawn routine test . Test result pregnancy test leukemia treatment look study . You pregnancy test perform study . If find eligible take part study , randomly assign ( roll dice ) one 3 treatment group ( Group 1 , Group 2 , Group 3 ) . Participants Groups 1 2 receive treatment ambisome . Participants Group 3 receive treatment voriconazole . Participants 3 group begin treatment 24 hour last dose chemotherapy . If assign Group 1 , receive ambisome vein continuous infusion 2 hour 1 time per day , 3 time week . If assign Group 2 , receive ambisome vein continuous infusion 2 hour 1 time per week . If assign Group 3 , take 2 pill mouth ( 1 hour breakfast ) 2 pill mouth ( 1 hour dinner ) 1 day , amount 4 pill total Day 1 . You take 1 pill mouth ( 1 hour breakfast ) 1 pill mouth ( 1 hour dinner ) everyday remainder study , amount 2 pill total day . You 1 teaspoon blood drawn routine test 2 time week . You also receive treatment standard care medication . These medication ( specify doctor ) use help decrease risk develop bacterial infection viral infection . If develop fever treatment study , chest x-ray CT scan chest within 3 day fever start . You may remain study 35 day ( receive chemotherapy first time ) 42 day ( prior chemotherapy ) . Your participation may end study study doctor think necessary , antifungal therapy require , develop intolerable side effect .</detailed_description>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<mesh_term>Amphotericin B</mesh_term>
	<mesh_term>Liposomal amphotericin B</mesh_term>
	<criteria>Diagnosis AML high risk MDS undergo induction chemotherapy first salvage chemotherapy . Age &gt; /=18 year . Patients must sign informed consent . Patients history anaphylaxis attribute azole amphotericin B compound . Patients clinical evidence indicate proven probable invasive fungal infection prior enrollment . Patients total bilirubin level &gt; 3 time upper normal limit ( i.e . &gt; 3.0 mg/dl ) ; serum glutamic pyruvic transaminase ( SGPT ) &gt; 5 time upper limit normal . Patients serum creatinine &gt; 2.0 mg/dl . Patients receive medication contraindicate use voriconazole . Patients participate study induction chemotherapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Voriconazole</keyword>
	<keyword>Vfend</keyword>
	<keyword>Liposomal amphotericin B</keyword>
	<keyword>Ambisome</keyword>
	<keyword>Acute Myelogenous Leukemia</keyword>
	<keyword>Myelodysplastic Syndrome</keyword>
	<keyword>AML</keyword>
	<keyword>MDS</keyword>
</DOC>